Global Biopharmaceutical Contract Manufacturing Market Insights, Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Growth Factors
1.2.3 Interferons
1.2.4 Monoclonal Antibodies
1.2.5 Recombinant Hormones
1.2.6 Vaccines
1.2.7 Insulin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2017-2028)
2.2 Biopharmaceutical Contract Manufacturing Growth Trends by Region
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Size by Region (2017-2022)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028)
2.3 Biopharmaceutical Contract Manufacturing Market Dynamics
2.3.1 Biopharmaceutical Contract Manufacturing Industry Trends
2.3.2 Biopharmaceutical Contract Manufacturing Market Drivers
2.3.3 Biopharmaceutical Contract Manufacturing Market Challenges
2.3.4 Biopharmaceutical Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2017-2022)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2017-2022)
3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2021
3.5 Biopharmaceutical Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2017-2022)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application
5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2017-2022)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type
6.2.1 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022)
6.2.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028)
6.2.3 North America Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Application
6.3.1 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022)
6.3.2 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028)
6.3.3 North America Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028)
6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country
6.4.1 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
6.4.2 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type
7.2.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022)
7.2.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028)
7.2.3 Europe Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Application
7.3.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022)
7.3.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028)
7.3.3 Europe Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028)
7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country
7.4.1 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
7.4.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
8.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type
8.2.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028)
8.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application
8.3.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028)
8.4 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region
8.4.1 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
9.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type
9.2.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022)
9.2.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028)
9.2.3 Latin America Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028)
9.3 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application
9.3.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022)
9.3.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028)
9.3.3 Latin America Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028)
9.4 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country
9.4.1 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
9.4.2 Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size (2017-2028)
10.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type
10.2.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Type (2017-2028)
10.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application
10.3.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Share by Application (2017-2028)
10.4 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country
10.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.1.5 Lonza Group Recent Developments
11.2 Baxter Biopharma Solutions
11.2.1 Baxter Biopharma Solutions Company Details
11.2.2 Baxter Biopharma Solutions Business Overview
11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.2.5 Baxter Biopharma Solutions Recent Developments
11.3 Samsung
11.3.1 Samsung Company Details
11.3.2 Samsung Business Overview
11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.3.5 Samsung Recent Developments
11.4 Fujifilm Diosynth Biotechnologies
11.4.1 Fujifilm Diosynth Biotechnologies Company Details
11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.4.5 Fujifilm Diosynth Biotechnologies Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Patheon
11.6.1 Patheon Company Details
11.6.2 Patheon Business Overview
11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.6.5 Patheon Recent Developments
11.7 Rentschler Biotechnologie
11.7.1 Rentschler Biotechnologie Company Details
11.7.2 Rentschler Biotechnologie Business Overview
11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.7.5 Rentschler Biotechnologie Recent Developments
11.8 Biomeva
11.8.1 Biomeva Company Details
11.8.2 Biomeva Business Overview
11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.8.5 Biomeva Recent Developments
11.9 Probiogen
11.9.1 Probiogen Company Details
11.9.2 Probiogen Business Overview
11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.9.5 Probiogen Recent Developments
11.10 Cytovance Biologics
11.10.1 Cytovance Biologics Company Details
11.10.2 Cytovance Biologics Business Overview
11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.10.5 Cytovance Biologics Recent Developments
11.11 KBI Biopharma
11.11.1 KBI Biopharma Company Details
11.11.2 KBI Biopharma Business Overview
11.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
11.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.11.5 KBI Biopharma Recent Developments
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Details
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
11.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.12.5 WuXi Biologics Recent Developments
11.13 Abzena
11.13.1 Abzena Company Details
11.13.2 Abzena Business Overview
11.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
11.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022)
11.13.5 Abzena Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Growth Factors
Table 3. Key Players of Interferons
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Recombinant Hormones
Table 6. Key Players of Vaccines
Table 7. Key Players of Insulin
Table 8. Key Players of Others
Table 9. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 10. Global Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 12. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2017-2022)
Table 13. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 14. Global Biopharmaceutical Contract Manufacturing Market Share by Region (2023-2028)
Table 15. Biopharmaceutical Contract Manufacturing Market Trends
Table 16. Biopharmaceutical Contract Manufacturing Market Drivers
Table 17. Biopharmaceutical Contract Manufacturing Market Challenges
Table 18. Biopharmaceutical Contract Manufacturing Market Restraints
Table 19. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million)
Table 20. Global Biopharmaceutical Contract Manufacturing Revenue Share by Players (2017-2022)
Table 21. Global Top Biopharmaceutical Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Table 22. Ranking of Global Top Biopharmaceutical Contract Manufacturing Companies by Revenue (US$ Million) in 2021
Table 23. Global 5 Largest Players Market Share by Biopharmaceutical Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 26. Date of Enter into Biopharmaceutical Contract Manufacturing Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2017-2022)
Table 30. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 31. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2023-2028)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 33. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application (2017-2022)
Table 34. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 35. Global Biopharmaceutical Contract Manufacturing Revenue Share by Application (2023-2028)
Table 36. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 38. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 39. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 40. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 41. North America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 42. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 43. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 44. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 45. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 46. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 47. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 48. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 49. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 50. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 51. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 52. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million)
Table 53. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million)
Table 54. Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 55. Latin America Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 56. Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 57. Latin America Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 58. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 59. Latin America Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Type (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Application (2023-2028) & (US$ Million)
Table 64. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million)
Table 65. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million)
Table 66. Lonza Group Company Details
Table 67. Lonza Group Business Overview
Table 68. Lonza Group Biopharmaceutical Contract Manufacturing Product
Table 69. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 70. Lonza Group Recent Developments
Table 71. Baxter Biopharma Solutions Company Details
Table 72. Baxter Biopharma Solutions Business Overview
Table 73. Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Product
Table 74. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 75. Baxter Biopharma Solutions Recent Developments
Table 76. Samsung Company Details
Table 77. Samsung Business Overview
Table 78. Samsung Biopharmaceutical Contract Manufacturing Product
Table 79. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 80. Samsung Recent Developments
Table 81. Fujifilm Diosynth Biotechnologies Company Details
Table 82. Fujifilm Diosynth Biotechnologies Business Overview
Table 83. Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Product
Table 84. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 85. Fujifilm Diosynth Biotechnologies Recent Developments
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Product
Table 89. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Patheon Company Details
Table 92. Patheon Business Overview
Table 93. Patheon Biopharmaceutical Contract Manufacturing Product
Table 94. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 95. Patheon Recent Developments
Table 96. Rentschler Biotechnologie Company Details
Table 97. Rentschler Biotechnologie Business Overview
Table 98. Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Product
Table 99. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 100. Rentschler Biotechnologie Recent Developments
Table 101. Biomeva Company Details
Table 102. Biomeva Business Overview
Table 103. Biomeva Biopharmaceutical Contract Manufacturing Product
Table 104. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 105. Biomeva Recent Developments
Table 106. Probiogen Company Details
Table 107. Probiogen Business Overview
Table 108. Probiogen Biopharmaceutical Contract Manufacturing Product
Table 109. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 110. Probiogen Recent Developments
Table 111. Cytovance Biologics Company Details
Table 112. Cytovance Biologics Business Overview
Table 113. Cytovance Biologics Biopharmaceutical Contract Manufacturing Product
Table 114. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 115. Cytovance Biologics Recent Developments
Table 116. KBI Biopharma Company Details
Table 117. KBI Biopharma Business Overview
Table 118. KBI Biopharma Biopharmaceutical Contract Manufacturing Product
Table 119. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 120. KBI Biopharma Recent Developments
Table 121. WuXi Biologics Company Details
Table 122. WuXi Biologics Business Overview
Table 123. WuXi Biologics Biopharmaceutical Contract Manufacturing Product
Table 124. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 125. WuXi Biologics Recent Developments
Table 126. Abzena Company Details
Table 127. Abzena Business Overview
Table 128. Abzena Biopharmaceutical Contract Manufacturing Product
Table 129. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2017-2022) & (US$ Million)
Table 130. Abzena Recent Developments
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2021 VS 2028
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2021 VS 2028
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Region: 2021 VS 2028
Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2021
Figure 24. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2021)
Figure 25. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2021
Figure 26. North America Biopharmaceutical Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 27. North America Biopharmaceutical Contract Manufacturing Market Size Market Share by Type (2017-2028)
Figure 28. North America Biopharmaceutical Contract Manufacturing Market Size Market Share by Application (2017-2028)
Figure 29. North America Biopharmaceutical Contract Manufacturing Market Size Share by Country (2017-2028)
Figure 30. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Europe Biopharmaceutical Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Europe Biopharmaceutical Contract Manufacturing Market Size Market Share by Type (2017-2028)
Figure 34. Europe Biopharmaceutical Contract Manufacturing Market Size Market Share by Application (2017-2028)
Figure 35. Europe Biopharmaceutical Contract Manufacturing Market Size Share by Country (2017-2028)
Figure 36. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Nordic Countries Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size Market Share by Type (2017-2028)
Figure 44. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size Market Share by Application (2017-2028)
Figure 45. Asia Pacific Biopharmaceutical Contract Manufacturing Market Size Share by Region (2017-2028)
Figure 46. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 52. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Latin America Biopharmaceutical Contract Manufacturing Market Size Market Share by Type (2017-2028)
Figure 54. Latin America Biopharmaceutical Contract Manufacturing Market Size Market Share by Application (2017-2028)
Figure 55. Latin America Biopharmaceutical Contract Manufacturing Market Size Share by Country (2017-2028)
Figure 56. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY (2017-2028) & (US$ Million)
Figure 59. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size Market Share by Type (2017-2028)
Figure 60. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size Market Share by Application (2017-2028)
Figure 61. Middle East and Africa Biopharmaceutical Contract Manufacturing Market Size Share by Country (2017-2028)
Figure 62. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 63. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 64. UAE Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 65. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 66. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 67. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 68. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 70. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 71. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 72. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 73. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 74. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 75. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 76. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 77. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2017-2022)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.